U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 8 of 8 results

IODIDE ION

MORE DETAILS

09G4I6V86Q

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7

ETHYLENE DIBROMIDE

MORE DETAILS

1N41638RNO

Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)

Iodine, atomic

MORE DETAILS

5D3DB66WM3

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7

POTASSIUM PHOSPHIDE

MORE DETAILS

2F09226A2C

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7

ETHYLENEDIAMINE DIHYDRIODIDE

MORE DETAILS

721M52NQ5L

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7

Potassium iodide

MORE DETAILS

1C4QK22F9J

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7

Sodium iodide

MORE DETAILS

F5WR8N145C

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7

HYDROGEN IODIDE

MORE DETAILS

694C0EFT9Q

Status:
US Approved Rx (1982)
First marketed in 1921
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
penetration of radioactive iodine into the thyroid gland
7
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966